ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Myopathies"

  • Abstract Number: 1064 • ACR Convergence 2020

    Anti-SMN Autoantibodies Are Associated with Systemic Sclerosis Small Bowel Involvement in anti-U1RNP Positive Autoimmune Myositis

    Caroline Vo1, Océane Landon-Cardinal2, Alexandra Albert3, Alain Meyer4, Valérie Leclair5, Josiane Bourré-Tessier2, Sabrina Hoa2, Eric Rich1, Jean-Richard Goulet1, Benjamin Ellezam6, Maude Bouchard-Marmen7, Martial Koenig8, Geneviève Gyger5, Ira N. Targoff9, Marie Hudson5, Minoru Satoh10, Marvin Fritzler11, Yves Troyanov12 and Jean-Luc Senécal2, 1Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Department of Medicine, Université de Montréal, Montréal, QC, Canada, 2Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 3Division of Rheumatology, Centre Hospitalier de l’Université Laval, Québec, QC, Canada, 4Service de rhumatologie et Centre de références des maladies autoimmunes rares, Hôpitaux universitaires de Strasbourg, Strasbourg, Alsace, France, 5Division of Rheumatology, Jewish General Hospital, Montréal, QC, Canada, 6Division of Pathology, Centre hospitalier universitaire Sainte-Justine, Montréal, QC, Canada, 7Division of Rheumatology, Centre Hospitalier de l’Université Laval, Department of Medicine, Université Laval, Québec, QC, Canada, 8Division of Internal Medicine, Centre hospitalier de l'Université de Montréal, Department of Medicine, Université de Montréal, Montréal, QC, Canada, 9University of Oklahoma Health Sciences Center, Oklahoma City, OK, 10Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan, 11Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 12Division of Rheumatology, Hôpital du Sacré-Coeur, Montréal, QC, Canada

    Background/Purpose: The survival of motor neuron (SMN)/gemin proteins are components of a multifunctional protein complex that plays an essential role in RNA metabolism. SMN is…
  • Abstract Number: 1069 • ACR Convergence 2020

    Scleromyositis Is Associated with Nailfold Capillary Abnormalities Compared to Immune-Mediated Necrotizing Myopathy

    Océane Landon-Cardinal1, Valérie Leclair2, Yves Troyanov3, Martial Koenig4, Alain Meyer5, Sabrina Hoa1, Josiane Bourré-Tessier1, Isabelle Ferdinand6, Jason Karamchandani7, Erin O'Ferrall8, Minoru Satoh9, Marvin Fritzler10, Benjamin Ellezam11, Jean-Luc Senécal1, Marie Hudson2 and Geneviève Gyger2, 1Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 2Division of Rheumatology, Jewish General Hospital, Montréal, QC, Canada, 3Division of Rheumatology, Hôpital du Sacré-Coeur, Montréal, QC, Canada, 4Division of Internal Medicine, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 5Service de rhumatologie et Centre de références des maladies autoimmunes rares, Hôpitaux universitaires de Strasbourg, Strasbourg, Alsace, France, 6Institut de Rhumatologie de Montréal, Montréal, QC, Canada, 7Department of Pathology, Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 8Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 9Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan, 10Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 11Division of Pathology, Centre hospitalier universitaire Sainte-Justine, Montréal, QC, Canada

    Background/Purpose: Scleromyositis (SM) is an emerging subgroup of autoimmune myositis associated with features of systemic sclerosis (SSc) and characterized by prominent vasculopathic features on ultrastructural…
  • Abstract Number: 1070 • ACR Convergence 2020

    Scleromyositis Is Associated with Distinct Muscle Vasculopathic Features

    Océane Landon-Cardinal1, Valérie Leclair2, Yves Troyanov3, Alain Meyer4, Sabrina Hoa1, Josiane Bourré-Tessier1, Valérie Nadon5, Julie Drouin6, Jason Karamchandani7, Erin O'Ferrall8, Minoru Satoh9, Marvin Fritzler10, Jean-Luc Senécal1, Marie Hudson2 and Benjamin Ellezam11, 1Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 2Division of Rheumatology, Jewish General Hospital, Montréal, QC, Canada, 3Division of Rheumatology, Hôpital du Sacré-Coeur, Montréal, QC, Canada, 4Service de rhumatologie et Centre de références des maladies autoimmunes rares, Hôpitaux universitaires de Strasbourg, Strasbourg, Alsace, France, 5Division of Rheumatology, Hôpital Notre-Dame, Montreal, Québec, Canada, Montréal, QC, Canada, 6Division of Rheumatology, Centre hospitalier régional de Trois-Rivières, Trois-Rivières, QC, Canada, 7Department of Pathology, Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 8Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 9Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan, 10Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 11Division of Pathology, Centre hospitalier universitaire Sainte-Justine, Montréal, QC, Canada

    Background/Purpose: Scleromyositis (SM) is an emerging subgroup of autoimmune myositis (AIM) associated with features of systemic sclerosis (SSc). Muscle biopsy studies are sparse and have…
  • Abstract Number: 1072 • ACR Convergence 2020

    Sexual Health Impairment in 62 Female Patients with Idiopathic Inflammatory Myopathies

    Barbora Hermankova1, Maja Spiritovic2, Sabina Oreska3, Hana Storkanova4, Hana Smucrova5, Martin Komarc6, Martin Klein4, Karel Pavelka7, Ladislav Šenolt7, Jiří Vencovský7, Heřman Mann4 and Michal Tomcik4, 1Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Hlavni mesto Praha, Czech Republic, 2Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Czech Republic, 3Institute of Rheumatology, Prague, Czech Republic. Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Praha 2, Czech Republic, 4Institute of Rheumatology, Prague, Czech Republic. Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 5Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 6Department of Methodology, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Czech Republic, 7Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of rare diseases characterized by chronic muscle inflammation and multiple organ involvement. These serious clinical manifestations…
  • Abstract Number: 1079 • ACR Convergence 2020

    Sex Differences in Antibody Profile, Phenotype, and Treatment Response in a Racially Diverse Population with Idiopathic Inflammatory Myopathies

    Ana Valle1, Jammie Law2, Katherine Mullins3 and Shereen Mahmood4, 1Albert Einstein College of Medicine, New York, NY, 2Montefiore Medical Center, Bronx, NY, 3Montefiore Medical Center, BROOKLYN, NY, 4Albert Einstein College of Medicine / Montefiore Medical Center, Wantagh, NY

    Background/Purpose: It is established that autoimmune diseases are more common in females than males. Large scale idiopathic inflammatory myopathy (IIM) registries have shown a similar…
  • Abstract Number: 1080 • ACR Convergence 2020

    Sensitivity and Specificity of the 2017 EULAR/ACR Criteria for Idiopathic Inflammatory Myopathies in a Cohort of Patients from Latin America

    Antonia Maria Valenzuela Vergara1, Magdalena Torres1 and Alejandro Deves1, 1Pontificia Universidad Catolica de Chile, Santiago de Chile, Chile

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of diseases characterized by muscle inflammation and internal organ involvement. The Bohan & Peter (B&P) criteria…
  • Abstract Number: 1083 • ACR Convergence 2020

    Alterations of Lipid Profile in IIM Patients Are Associated with Disease Activity, Duration, and Glucocorticoid Treatment

    Sabina Oreska1, Hana Storkanova2, Maja Spiritovic3, Barbora Hermankova4, Michal Vrablik5, Karel Pavelka6, Ladislav Šenolt6, Heřman Mann2, Jiří Vencovský6 and Michal Tomcik7, 1Institute of Rheumatology, Prague, Czech Republic. Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Praha 2, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic. Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 3Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic, Prague, Czech Republic, 4Faculty of Physical Education and Sport, Department of Physiotherapy, Charles University, Prague, Czech Republic,, Prague, Czech Republic, 53rd Department of Internal Medicine, General University Hospital, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 6Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 7Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are characterized by skeletal muscle and organ involvement and chronic course. Systemic inflammation, limited mobility, and glucocorticoid treatment can have…
  • Abstract Number: 0085 • ACR Convergence 2020

    Classifications of Inflammatory Myopathies: Differentially Expressed Membrane-Bound Complement Regulators Allow Specific Patterns of Membrane Attack Complex Deposition

    Fadi Charouf1, Netanel Karbian1, Itamar Altman1, Yakov Fellig1 and Dror Mevorach1, 1Hadassah-University Hospital, Jerusalem, Yerushalayim, Israel

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are a group of heterogeneous disorders that typically present with proximal muscle weakness. According to the classification criteria, IMs are…
  • Abstract Number: 1086 • ACR Convergence 2020

    The Diagnostic Value and Clinical Significance of Myositis-Specific Antibodies in Patients Suspected to Have Autoimmune Myopathies and/or Autoimmune Rheumatic Diseases

    Sarah El Chami1, Christopher Williams1, Ghaith Noaiseh1, Amrita Bath1 and Duaa Jabari1, 1The University of Kansas Health System, Kansas city, KS

    Background/Purpose: Myositis-specific antibodies (MSA) are thought to be highly specific in patients with idiopathic inflammatory myopathies.[1] However, in clinical practice these antibodies are frequently found…
  • Abstract Number: 0932 • ACR Convergence 2020

    Skeletal Muscle Involvement in Systemic Sclerosis Predisposes to Severe Gastrointestinal Tract and Cardiac Muscle Disease

    Reshad Mahmud1, Lei Zhu2, Maureen Laffoon2, Thomas Medsger3 and Robyn Domsic4, 1UPMC, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3University of Pittsburgh School of Medicine, Verona, PA, 4University of Pittsburgh School of Medicine, Pittsburgh, PA

    Background/Purpose: Tissues containing muscle cells are affected in systemic sclerosis (SSc) patients in different organ systems: skeletal muscle, cardiac muscle and gastrointestinal (GI) smooth muscle. …
  • Abstract Number: 1088 • ACR Convergence 2020

    Recruitment Rates of Virtual Remote Research (Tele-Research) in Myositis

    Siamak Moghadam-Kia1, Chester Oddis2, Swamy Venturupalli3, Shalini Mahajan4, Daphne Scaramangas Plumley5, Dana Ascherman6, Nicole Neiman7, Faith Onelangsy7, Diane Koontz1, Kim Goldby-Reffner7, Sedin Dzanco7, Lei Zhu6 and Rohit Aggarwal6, 1University of Pittsburgh Medical Center, Pittsburgh, PA, 2Department of Medicine, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, 3Cedars Sinai Medical Center, Los Angeles, 4Attune Health, Los Angeles, 5Attune Health, Los Angeles, CA, 6University of Pittsburgh, Pittsburgh, PA, 7UPMC, Pittsburgh

    Background/Purpose: There is a paucity of randomized, controlled clinical trials in myositis. Subject enrollment and retention in clinical trials for this rare, heterogeneous disease has…
  • Abstract Number: 0933 • ACR Convergence 2020

    Advanced Multiparametric Magnetic Resonance Imaging of Muscle for Detection and Quantification of Muscle Disease in Systemic Sclerosis

    Julie Paik1, Fredrick Wigley2, Laura Fayad3, Laura Hummers4 and Michael Jacobs1, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Joh, Baltimore, MD, 4Johns Hopkins Univerisity, Ellicott City, MD

    Background/Purpose: Skeletal myopathy in systemic sclerosis (SSc) is underappreciated yet an important manifestation of SSc. While it has been reported that there are distinct histopathologic…
  • Abstract Number: 1096 • ACR Convergence 2020

    Assessing Interstitial Lung Disease in a Racially Diverse Population with Idiopathic Inflammatory Myositis

    Jammie Law1, Ana Valle2, Katherine Mullins3 and Shereen Mahmood4, 1Montefiore Medical Center, Bronx, NY, 2Albert Einstein College of Medicine, New York, NY, 3Montefiore Medical Center, BROOKLYN, NY, 4Albert Einstein College of Medicine / Montefiore Medical Center, Wantagh, NY

    Background/Purpose: Interstitial lung disease (ILD) is a common extra-muscular manifestation of Idiopathic Inflammatory Myositis (IIM) and increases risk of mortality. Prior studies and registries have focused on either smaller cohorts or predominantly Caucasian/European populations. Our aim was to better characterize the…
  • Abstract Number: 0958 • ACR Convergence 2020

    Tocilizumab in Myositis: Results of a Phase IIb Double-Blind Randomized Controlled Trial

    Rohit Aggarwal1, Howard Rockette2, Swamy Venturupalli3, Galina Marder4, Mazen Dimachkie5, David Gazeley6, Floranne C. Ernste7, Leslie Crofford8, Siamak Moghadam-Kia9, Diane Koontz9, Lei Zhu1 and Chester Oddis10, 1University of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, 3Cedars Sinai Medical Center, Los Angeles, 4Northwell, New York, 5Univeristy of Kansas, Medical Center, Kansas City, KS, 6Medical College of Wisconsin, Wauwatosa, WI, 7Mayo Clinic, Rochester, 8Vanderbilt University Medical Center, Nashville, 9University of Pittsburgh Medical Center, Pittsburgh, PA, 10Department of Medicine, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: To assess the efficacy and tolerability of tocilizumab (anti-IL-6R, TCZ), in a multi-center, randomized, double blind, placebo-controlled trial in refractory adult dermatomyositis (DM) and…
  • Abstract Number: 1097 • ACR Convergence 2020

    Immunophenotypic Characterization of Myeloid Derived Supressor Cells (MDSCs) and Their Relationship to the Clinical Characteristics of Patients with Inflammatory Myopathies

    Hector Culebro1, Jose Torres-Ruiz2, Fabiola Cassiano Quezada1 and Alfredo Perez Fragoso1, 1INCMNSZ, MEXICO, Mexico, 2NIAMS, National Institute of Health, Bethesda

    Background/Purpose: Myeloid derived suppressor cells (MDSCs) including their granulocyte (Gr-MDSCs) and monocyte (Mo-MDSCs) subtypes constitute a cellular subset with potent immune regulatory capacity. An augmented…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology